These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 761333

  • 1. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
    Packer M, Meller J, Gorlin R, Herman MV.
    Circulation; 1979 Mar; 59(3):531-9. PubMed ID: 761333
    [No Abstract] [Full Text] [Related]

  • 2. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [Abstract] [Full Text] [Related]

  • 3. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP, Becque O, Berthout P, Vial Y, Magnin D, Bernard Y, Maurat JP.
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract] [Full Text] [Related]

  • 4. Management of refractory CHF with prazosin: importance of tolerance and tachyphylaxis.
    Awan NA, Evenson MK, Needham KE, Mason DT.
    Acta Med Scand Suppl; 1981 Jun; 652():115-24. PubMed ID: 6949458
    [No Abstract] [Full Text] [Related]

  • 5. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL, Hall D, Rudolph W.
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract] [Full Text] [Related]

  • 6. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 7. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

  • 8. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA, Mason DT.
    Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616
    [No Abstract] [Full Text] [Related]

  • 9. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H, Boch H, Lösse B.
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract] [Full Text] [Related]

  • 10. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK, Awan NA, Mason DT.
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract] [Full Text] [Related]

  • 11. Loss of prazosin effect in severe chronic CHF.
    Ihlen H, Thaulow E, Kjekshus J, Forfang K.
    Acta Med Scand Suppl; 1981 Apr; 652():149-54. PubMed ID: 6949461
    [No Abstract] [Full Text] [Related]

  • 12. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.
    Med J Aust; 1980 Jul 26; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul 26; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 14. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL, Chatterjee K, Benge W, Parmley WW, Hiramatsu B.
    Circulation; 1982 Apr 26; 65(4):671-8. PubMed ID: 7037220
    [No Abstract] [Full Text] [Related]

  • 15. [Hemodynamic effects of prazosin in heart failure].
    Bassand JP, Becque O, Vial Y, Berthout P, Maurat JP.
    Nouv Presse Med; 1979 Nov 12; 8(44):3663. PubMed ID: 534219
    [No Abstract] [Full Text] [Related]

  • 16. [Echocardiographic, hemodynamic and clinical effects of prazosin in subjects with severe cardiopathy caused by Chagas disease].
    Pileggi F, Bellotti G, Galiano N, de Moraes V, Ramires JA, de Mello CP, Décourt LV.
    Cardiology; 1980 Nov 12; 66 Suppl 2():177-85. PubMed ID: 7285028
    [No Abstract] [Full Text] [Related]

  • 17. Effects of red rest and prazosin in congestive heart failure.
    Thaulow E, Ihlen H, Kjekshus J, Forfang K, Storstein O.
    Acta Med Scand; 1982 Nov 12; 212(3):131-6. PubMed ID: 7148503
    [Abstract] [Full Text] [Related]

  • 18. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR, Miles D, Mehta J.
    Cardiology; 1980 Nov 12; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract] [Full Text] [Related]

  • 19. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    Stein L, Henry DP, Weinberger MH.
    Am J Med; 1981 Apr 12; 70(4):825-32. PubMed ID: 7011023
    [Abstract] [Full Text] [Related]

  • 20. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T, Suzuki A, Yamamoto T, Takahashi S, Kimata S, Hirosawa K.
    Kokyu To Junkan; 1979 Sep 12; 27(9):991-7. PubMed ID: 538350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.